Appraising the small airways in asthma

Current Opinion in Pulmonary Medicine

Volumn 18, Issue 1, 2012, Pages 23-28

  Johnson, Jill R ^a   Hamid, Qutayba ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

asthma; inflammation; pharmacotherapy; physiology; small airways

Indexed keywords

BIOLOGICAL MARKER; CORTICOSTEROID; NITRIC OXIDE;

AIRWAY REMODELING; ALLERGIC ASTHMA; ASTHMA; DRUG DELIVERY SYSTEM; FUNCTIONAL ASSESSMENT; INFLAMMATION; LUNG FUNCTION; MAST CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW;

ADRENAL CORTEX HORMONES; AIRWAY REMODELING; AIRWAY RESISTANCE; ANTI-INFLAMMATORY AGENTS; ASTHMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG; NITRIC OXIDE; RESPIRATORY FUNCTION TESTS;

EID: 83155173901     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32834dd8c2     Document Type: Review

References (32)

1. Hyde DM, Hamid Q, Irvin CG. Anatomy, pathology, and physiology of the tracheobronchial tree: emphasis on the distal airways. J Allergy Clin Immunol 2009; 124:S72-S77.
2. Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ. Noneosinophilic corticosteroid unresponsive asthma. Lancet 1999; 353:2213-2214.
3. Schleich FN, Seidel L, Sele J, et al. Exhaled nitric oxide thresholds associated with a sputum eosinophil count 〉/143% in a cohort of unselected patients with asthma. Thorax 2010; 65:1039-1044.
4. Verbanck S, Schuermans D, Vincken W. Inflammation and airway function in the lung periphery of patients with stable asthma. J Allergy Clin Immunol 2010; 125:611-616.
5. Williamson PA, Clearie K, Menzies D, et al. Assessment of small-airways disease using alveolar nitric oxide and impulse oscillometry in asthma and COPD. Lung 2011; 189:121-129.
6. Zietkowski Z, Skiepko R, Tomasiak-Lozowska MM, Bodzenta-Lukaszyk A. Anti-IgE therapy with omalizumab decreases endothelin-1 in exhaled breath condensate of patients with severe persistent allergic asthma. Respiration 2010; 80:534-542.
7. Zietkowski Z, Tomasiak-Lozowska MM, Skiepko R, et al. Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients. Respir Res 2010; 11:110.
8. Zietkowski Z, Skiepko R, Tomasiak-Lozowska MM, et al. RANTES in exhaled breath condensate of patients with severe persistent allergic asthma during omalizumab therapy. Int Arch Allergy Immunol 2011; 154:25-32.
9. Teng Y, Sun P, Zhang J, et al. Hydrogen peroxide in exhaled breath condensate in asthma: a promising biomarker? Chest 2011; 140:108-116.
10. Sethi JM, White AM, Patel SA, et al. Bronchoprovocation testing in asthma: effect on exhaled monoxides. J Breath Res 2010; 4:047104.
11. Boulet LP. Transbronchial biopsy as a tool to evaluate small-airways disease in asthma. Pros Eur Respir J 2002; 20:247-248.
12. Andersson CK, Bergqvist A, Mori M, et al. Mast cell-associated alveolar inflammation in patients with atopic uncontrolled asthma. J Allergy Clin Immunol 2011; 127:905-912.
13. Balzar S, Chu HW, Strand M, Wenzel S. Relationship of small airway chymase-positive mast cells and lung function in severe asthma. Am J Respir Crit Care Med 2005; 171:431-439. (Pubitemid 40444242)
14. Bentley AM, Hamid Q, Robinson DS, et al. Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med 1996; 153:551-556.
15. Dolhnikoff M, da Silva LF, de Araujo BB, et al. The outer wall of small airways is a major site of remodeling in fatal asthma. J Allergy Clin Immunol 2009; 123:1090-1097.
16. Pechkovsky DV, Hackett TL, An SS, et al. Human lung parenchyma but not proximal bronchi produces fibroblasts with enhanced TGF-beta signaling and alpha-SMA expression. Am J Respir Cell Mol Biol 2010; 43:641-651.
17. Leuppi JD, Salome CM, Jenkins CR, et al. Markers of airway inflammation and airway hyperresponsiveness in patients with well controlled asthma. Eur Respir J 2001; 18:444-450. (Pubitemid 32895628)
18. Sigurs N, Aljassim F, Kjellman B, et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 2010; 65:1045-1052.
19. Goldman MD, Nazeran H, Ramos C, et al. Electrical circuit models of the human respiratory system reflect small airway impairment measured by impulse oscillation (IOS). Conf Proc IEEE Eng Med Biol Soc 2010; 2010:2467-2472.
20. Keen C, Olin AC, Wennergren G, Gustafsson P. Small airway function, exhaled NO and airway hyper-responsiveness in paediatric asthma. Respir Med 2011; 105:1476-1484.
21. Kelly VJ, Brown NJ, King GG, Thompson BR. A method to determine in vivo, specific airway compliance, in humans. Med Biol Eng Comput 2010; 48:489-496.
22. Mugler JP III, Altes TA, Ruset IC, et al. Simultaneous magnetic resonance imaging of ventilation distribution and gas uptake in the human lung using hyperpolarized xenon-129. Proc Natl Acad Sci USA 2010; 107:21707-21712.
23. De Lange EE, Altes TA, Patrie JT, et al. Evaluation of asthma with hyperpolarized helium-3 MRI: correlation with clinical severity and spirometry. Chest 2006; 130:1055-1062. (Pubitemid 44583735)
24. Campana L, Kenyon J, Zhalehdoust-Sani S, et al. Probing airway conditions governing ventilation defects in asthma via hyperpolarized MRI image functional modeling. J Appl Physiol 2009; 106:1293-1300.
25. Tustison NJ, Altes TA, Song G, et al. Feature analysis of hyperpolarized helium-3 pulmonary MRI: a study of asthmatics versus nonasthmatics. Magn Reson Med 2010; 63:1448-1455.
26. Vanden Burgt JA, BusseWW,Martin RJ, et al. Efficacy and safety overview of a newinhaledcorticosteroid,QVAR(hydrofluoroalkane-beclomethasoneextrafine inhalation aerosol), in asthma. J Allergy Clin Immunol 2000; 106:1209-1226.
27. Gentile DA, Skoner DP. New asthma drugs: small molecule inhaled corticosteroids. Curr Opin Pharmacol 2010; 10:260-265.
28. Hoshino M. Comparison of effectiveness in ciclesonide and fluticasone propionate on small airway function in mild asthma. Allergol Int 2010; 59:59-66.
29. Scichilone N, Battaglia S, Sorino C, et al. Effects of extra-fine inhaled beclomethasone/formoterol on both large and small airways in asthma. Allergy 2010; 65:897-902.
30. Kraft M, Cairns CB, Ellison MC, et al. Improvements in distal lung function correlate with asthma symptoms after treatment with oral montelukast. Chest 2006; 130:1726-1732. (Pubitemid 46033426)
31. Fritscher LG, Rodrigues MT, Zamel N, Chapman KR. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma. Respir Med 2009; 103:296-300.
32. Ghiro L, Zanconato S, Rampon O, et al. Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children. Eur Respir J 2002; 20:630-634.